Tourette Syndrome, which is characterized by vocal and motor tics, can be difficult for affected children and their loved ones. The Michigan Clinical Research Institute is a site for two research trials which aim to reduce symptoms associated with Tourette Syndrome. Specifically, medications which show promise to alleviate tics in children and adolescents with Tourette Syndrome.
What to Expect?
First, a consultation visit to assess eligibility and ensure your interest in participation.
Participation will include taking a medication on a daily basis and regular site study visits.
Study visits consist of psychiatric and physical evaluations, along with vital assessments such as EKG, blood pressure, and laboratory tests.
Medication and care related to research will not be charged.
Families will be compensated for their time and travel.
To learn more about participation, please call (734) 834 - 8954 ext. 2 or fill out the fields below.
*Disclosure: Dr. Rajarethinam, the Principal Investigator, conducts contract research for various pharmaceutical companies, including: Johnson & Johnson, Neurocrine, Otsuka, Astellas, Jansson, and a variety of others. He also participates in promotional meetings for Neurocrine Sciences.